scispace - formally typeset
T

Takaaki Koshiba

Researcher at Kyoto University

Publications -  32
Citations -  1542

Takaaki Koshiba is an academic researcher from Kyoto University. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 16, co-authored 32 publications receiving 1343 citations. Previous affiliations of Takaaki Koshiba include The Catholic University of America.

Papers
More filters
Journal ArticleDOI

2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.

Anthony J. Demetris, +76 more
TL;DR: New recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization are included.
Journal ArticleDOI

Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation.

TL;DR: Systemically phenotyped peripheral blood mononuclear cells from operationally tolerant patients to provide important clues for reliable indicators of tolerance after LDLT and the contribution of those subsets to the tolerant state remains elusive.
Journal ArticleDOI

Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation.

TL;DR: Operationally tolerant patients, albeit showing normal liver function, exhibited decrease in size and increase in number of the bile duct and the fibrosis to a greater extent, compared with patients on maintenance immunosuppression, and warrants serial protocol biopsy before and after complete cessation of immunosppression even in the presence ofnormal liver function.
Journal ArticleDOI

The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.

TL;DR: This is the first report showing that CD4+Foxp3+ cells are present within grafts in a subset of tolerant patients after human liver transplantation, and the assessment of intragraft expression of Foxp3 protein, but not Foxp 3 mRNA, can aid the identification of living-donor liver-transplantation recipients who can successfully withdraw IS.